Patients provide positive feedback for the clinical workflow
MONDAY, April 28, 2025 (HealthDay News) — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible and acceptable to patients, according to a study published online April 28 in Cancer.
Lea Haverbeck Simon, Ph.D., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues evaluated the feasibility and acceptability of the CORE clinical workflow algorithm. The analysis included 72 patients with newly diagnosed stage I to III breast cancer needing surgery as first-line treatment who were randomly assigned (2:1) to CORE or standard of care.
The researchers found that 93 percent of participants in CORE completed the triaging tool, demonstrating its feasibility. Among those triaged to a service pathway, 62 percent completed their referral. Focus groups provided primarily positive feedback.
“CORE may serve as a model workflow algorithm aimed to integrate both exercise and rehabilitation services from time of diagnosis and beyond,” senior author Adriana M. Coletta, Ph.D., also from the Huntsman Cancer Institute, said in a statement. “Findings from this trial support national efforts led by the American College of Sports Medicine to integrate exercise and rehabilitation services as part of routine cancer care.”
One author disclosed receiving personal/consulting fees from ImpediMed.
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease